# An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During Colonoscopy

> **NCT00261599** · PHASE3 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 300 (—)

## Conditions studied

- Conscious Sedation

## Interventions

- **DRUG:** AQUAVAN® (fospropofol disodium) Injection
- **DRUG:** Midazolam HCI

## Key facts

- **NCT ID:** NCT00261599
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** —
- **Final completion:** 2006-10
- **Target enrollment:** 300 (—)
- **Last updated:** 2008-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00261599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00261599, "An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During Colonoscopy". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00261599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*